PTGDR and asthma: Collectively, these data indicate that DP2 antagonism or DP1 agonism during a virus-induced exacerbation of asthma resolves established airway remodeling, including the increased ASM mass, whereas corticosteroid treatment only prevents the increase in mucus production.